-transparent.png){kind=logo}
Polymorphonuclear leukocytes (PMN) generate highly reactive oxygen derived free radicals that may cause lipoprotein lipid oxidation and so contribute to the pathogenesis of atherosclerosis. On the other hand it has been shown that lipoproteins can alter cell functions in vitro. We therefore studied the effects of atherogenic lipoproteins, VLDL and LDL, on the production of superoxide anion by human PMN in the presence or absence of formyl-methionyl-leucyl-phenylalanine (fMLP). VLDL and LDL stimulate PMN superoxide production and potentialize PMN stimulation by fMLP. The lipid moiety of the lipoproteins might be mainly involved in these effects. The binding of radio-labelled fMLP to its specific membrane receptor was significantly enhanced in the presence of VLDL and only slightly in the presence of LDL. The study of the signal transduction suggests that modulation of phospholipase D and A2 activities could be involved in the modification by LDL of PMN response to fMLP.
R Couderc, and
C Bonneau, and
M Tissot, and
S Bailleul, and
M Roch-Arveiller, and
J P Giroud
August 1990,
Cancer,
R Couderc, and
C Bonneau, and
M Tissot, and
S Bailleul, and
M Roch-Arveiller, and
J P Giroud
June 1983,
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
R Couderc, and
C Bonneau, and
M Tissot, and
S Bailleul, and
M Roch-Arveiller, and
J P Giroud
June 1987,
Nihon Shishubyo Gakkai kaishi,
R Couderc, and
C Bonneau, and
M Tissot, and
S Bailleul, and
M Roch-Arveiller, and
J P Giroud
May 1989,
The Journal of allergy and clinical immunology,
R Couderc, and
C Bonneau, and
M Tissot, and
S Bailleul, and
M Roch-Arveiller, and
J P Giroud
March 1988,
Pediatric research,
R Couderc, and
C Bonneau, and
M Tissot, and
S Bailleul, and
M Roch-Arveiller, and
J P Giroud
January 2000,
Acta diabetologica,
R Couderc, and
C Bonneau, and
M Tissot, and
S Bailleul, and
M Roch-Arveiller, and
J P Giroud
September 1986,
Critical care medicine,
R Couderc, and
C Bonneau, and
M Tissot, and
S Bailleul, and
M Roch-Arveiller, and
J P Giroud
January 1993,
Free radical research communications,
R Couderc, and
C Bonneau, and
M Tissot, and
S Bailleul, and
M Roch-Arveiller, and
J P Giroud
May 1997,
The Journal of pharmacy and pharmacology,
R Couderc, and
C Bonneau, and
M Tissot, and
S Bailleul, and
M Roch-Arveiller, and
J P Giroud
December 1989,
Critical care medicine,
